Develops small molecule drugs targeting cellular motor proteins for CNS disorders and cancer, with programs in glioblastoma and addiction.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
Myosin Therapeutics is a biopharmaceutical company developing novel medications that target cellular motor proteins, specifically focusing on therapies for central nervous system disorders and oncology. Their platform is designed to create small molecule modulators of molecular nanomotors, with lead programs addressing glioblastoma and stimulant use disorder.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Investors
DeepWork Capital
Myosin Therapeutics Valuations & Financials
View real-time NPM data on Myosin Therapeutics stock including daily Myosin Therapeutics stock price estimates, valuation history, and historical share price information. Access Myosin Therapeutics financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track Myosin Therapeutics pricing across six independent market signals. Looking for private company due diligence data sources on Myosin Therapeutics? Get in touch to learn more.
Similar Companies
like Myosin Therapeutics
Podium
Enterprise Software
Customer messaging platform enabling companies to connect at critical touch points.
MindTickle
Enterprise Software
Enhances sales teams with learning and analytics tools that strengthen preparedness and elevate performance in customer engagements.
Machina Labs
AI & Machine Learning
Develops robotic manufacturing technology that produces metal parts efficiently using automation and advanced fabrication methods.
Vantage
Enterprise Software
A cloud cost transparency platform that offers dashboards and tools to monitor spending, allocate costs, and identify savings opportunities.
Urotronic
Healthcare & Life Sciences
Develops innovative medical devices and technologies for treating urological conditions, focusing on minimally invasive urinary tract solutions.
Capstan Medical
Healthcare & Life Sciences
Merges surgical robotics with catheter-based technology to repair and replace heart valves.
Nada
FinTech
Offers a platform that manages and secures business payments while integrating with workflows to simplify financial operations.
FAQ
We have answers
Myosin Therapeutics stock does not trade on public stock exchanges. Myosin Therapeutics stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Myosin Therapeutics stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Myosin Therapeutics Stock does not trade on public stock exchanges. In order to sell Myosin Therapeutics shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Myosin Therapeutics does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Myosin Therapeutics share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for Myosin Therapeutics stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Myosin Therapeutics stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Myosin Therapeutics stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Myosin Therapeutics is a private company and has not had an IPO. There is currently no Myosin Therapeutics IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Myosin Therapeutics IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
